Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Eli Lilly developed it as a triple receptor agonist
The human data, while limited, represent the most controlled safety evidence available for either peptide
Category 2 designations eliminated major revenue sources overnight
We hypothesized that MOTS-c can mimic the effects of exercise by improving cardiac dysfunction in a rat model of T2DM.The underlying mechanism may be that MOTS-c improves the oxidative stress pathway involving Kelch-like ECH-associated protein 1 (Keap1)Nrf2
In plain terms: it turns up the dial on breaking fat down and turns down the dial on creating new fat deposits
US$ 25.45
US$ 29.49
US$ 29.43
US$ 22.13
